Elite Pharmaceuticals Inc (ELTP)
0.5177
-0.06
(-9.98%)
USD |
OTCM |
Nov 14, 16:00
Elite Pharmaceuticals Free Cash Flow (Quarterly): 1.466M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.466M |
| March 31, 2024 | 1.656M |
| December 31, 2023 | -2.802M |
| September 30, 2023 | -0.2359M |
| June 30, 2023 | -2.710M |
| March 31, 2023 | 2.432M |
| December 31, 2022 | -0.5686M |
| September 30, 2022 | -3.610M |
| June 30, 2022 | -0.6521M |
| March 31, 2022 | 1.341M |
| December 31, 2021 | 2.952M |
| September 30, 2021 | 0.0064M |
| June 30, 2021 | 1.710M |
| March 31, 2021 | -0.9343M |
| December 31, 2020 | 1.185M |
| September 30, 2020 | 1.820M |
| June 30, 2020 | 0.7934M |
| March 31, 2020 | -1.238M |
| December 31, 2019 | -0.3122M |
| September 30, 2019 | -0.464M |
| June 30, 2019 | 0.1853M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.287M |
| September 30, 2018 | -1.501M |
| June 30, 2018 | -1.888M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.9118M |
| December 31, 2017 | -0.3929M |
| September 30, 2017 | -2.352M |
| June 30, 2017 | -1.427M |
| March 31, 2017 | -4.369M |
| December 31, 2016 | -1.019M |
| September 30, 2016 | -2.552M |
| June 30, 2016 | -1.049M |
| March 31, 2016 | 0.0356M |
| December 31, 2015 | -1.738M |
| September 30, 2015 | -4.186M |
| June 30, 2015 | 1.174M |
| March 31, 2015 | -4.455M |
| December 31, 2014 | -2.990M |
| September 30, 2014 | -4.757M |
| June 30, 2014 | -4.898M |
| March 31, 2014 | -1.602M |
| December 31, 2013 | -1.742M |
| September 30, 2013 | -1.024M |
| June 30, 2013 | -0.4091M |
| March 31, 2013 | -0.2477M |
| December 31, 2012 | -0.3709M |
| September 30, 2012 | -0.9508M |
| June 30, 2012 | -0.3286M |
| March 31, 2012 | 0.2281M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.610M
Minimum
Sep 2022
2.952M
Maximum
Dec 2021
0.1211M
Average
0.0064M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 200.30M |
| BioCardia Inc | -1.315M |
| Zevra Therapeutics Inc | -19.11M |
| Verrica Pharmaceuticals Inc | -8.574M |
| Terns Pharmaceuticals Inc | -16.19M |